Bioceres Crop Solutions Corp.

NasdaqGS:BIOX 주식 보고서

시가총액: US$385.3m

Bioceres Crop Solutions 미래 성장

Future 기준 확인 4/6

Bioceres Crop Solutions은 연간 수입과 매출이 각각 42.3%와 9.6% 증가할 것으로 예상되고 EPS는 연간 40.7%만큼 증가할 것으로 예상됩니다.

주요 정보

42.3%

수익 성장률

40.7%

EPS 성장률

Chemicals 수익 성장17.1%
매출 성장률9.6%
향후 자기자본 수익률n/a
애널리스트 커버리지

Low

마지막 업데이트19 Nov 2024

최근 미래 성장 업데이트

Recent updates

Bioceres Is Getting Cheaper, Not Yet An Opportunity But More Interesting

Nov 13

Take Care Before Jumping Onto Bioceres Crop Solutions Corp. (NASDAQ:BIOX) Even Though It's 29% Cheaper

Sep 28
Take Care Before Jumping Onto Bioceres Crop Solutions Corp. (NASDAQ:BIOX) Even Though It's 29% Cheaper

Bioceres' Q4 2024 Shows Challenges With HB4 Rollout, Still A Hold Despite Lower Stock Prices

Sep 17

These 4 Measures Indicate That Bioceres Crop Solutions (NASDAQ:BIOX) Is Using Debt Extensively

Aug 03
These 4 Measures Indicate That Bioceres Crop Solutions (NASDAQ:BIOX) Is Using Debt Extensively

Bioceres Needs To Add Clarity Around Borrowings

Mar 23

Bioceres Crop Solutions (NASDAQ:BIOX) Takes On Some Risk With Its Use Of Debt

Feb 03
Bioceres Crop Solutions (NASDAQ:BIOX) Takes On Some Risk With Its Use Of Debt

Does Bioceres Crop Solutions (NASDAQ:BIOX) Have A Healthy Balance Sheet?

Oct 04
Does Bioceres Crop Solutions (NASDAQ:BIOX) Have A Healthy Balance Sheet?

Bioceres Crop Solutions Corp.'s (NASDAQ:BIOX) Popularity With Investors Is Clear

Jun 21
Bioceres Crop Solutions Corp.'s (NASDAQ:BIOX) Popularity With Investors Is Clear

Here's Why Bioceres Crop Solutions (NASDAQ:BIOX) Is Weighed Down By Its Debt Load

May 09
Here's Why Bioceres Crop Solutions (NASDAQ:BIOX) Is Weighed Down By Its Debt Load

Bioceres: A Resilient Small Cap With Conference Appearances After Thursday's Earnings

Sep 06

Bioceres Crop Solutions jumps 15% after investor pitch

Aug 23

We Think Bioceres Crop Solutions (NASDAQ:BIOX) Is Taking Some Risk With Its Debt

Apr 10
We Think Bioceres Crop Solutions (NASDAQ:BIOX) Is Taking Some Risk With Its Debt

Bioceres Has Not Resolved Its Major Risks And Is Growing Based On Commodities Bullishness

Mar 31

Is Now The Time To Look At Buying Bioceres Crop Solutions Corp. (NASDAQ:BIOX)?

Mar 17
Is Now The Time To Look At Buying Bioceres Crop Solutions Corp. (NASDAQ:BIOX)?

Is Bioceres Crop Solutions Corp. (NASDAQ:BIOX) Trading At A 21% Discount?

Nov 13
Is Bioceres Crop Solutions Corp. (NASDAQ:BIOX) Trading At A 21% Discount?

Bioceres Crop Solutions (NASDAQ:BIOX) Shareholders Will Want The ROCE Trajectory To Continue

Jul 08
Bioceres Crop Solutions (NASDAQ:BIOX) Shareholders Will Want The ROCE Trajectory To Continue

Estimating The Intrinsic Value Of Bioceres Crop Solutions Corp. (NASDAQ:BIOX)

Jun 16
Estimating The Intrinsic Value Of Bioceres Crop Solutions Corp. (NASDAQ:BIOX)

What Does Bioceres Crop Solutions Corp.'s (NASDAQ:BIOX) Share Price Indicate?

May 26
What Does Bioceres Crop Solutions Corp.'s (NASDAQ:BIOX) Share Price Indicate?

Bioceres partners with Havanna to offer consumers HB4 wheat-based sustainable products

May 10

Does Bioceres Crop Solutions (NASDAQ:BIOX) Have A Healthy Balance Sheet?

May 05
Does Bioceres Crop Solutions (NASDAQ:BIOX) Have A Healthy Balance Sheet?

Bioceres Crop Solutions (NYSEMKT:BIOX) Shareholders Will Want The ROCE Trajectory To Continue

Apr 05
Bioceres Crop Solutions (NYSEMKT:BIOX) Shareholders Will Want The ROCE Trajectory To Continue

Are Investors Undervaluing Bioceres Crop Solutions Corp. (NYSEMKT:BIOX) By 22%?

Mar 10
Are Investors Undervaluing Bioceres Crop Solutions Corp. (NYSEMKT:BIOX) By 22%?

Bioceres Crop Solutions (NYSEMKT:BIOX) Shareholders Booked A 53% Gain In The Last Year

Feb 12
Bioceres Crop Solutions (NYSEMKT:BIOX) Shareholders Booked A 53% Gain In The Last Year

수익 및 매출 성장 예측

NasdaqGS:BIOX - 애널리스트의 미래 추정치 및 과거 재무 데이터 (USD Millions )
날짜수익수익잉여 현금 흐름작전 현금평균 애널리스트 수
6/30/20275715532N/A1
6/30/20265112951N/A3
6/30/20254631149N/A4
9/30/20244412N/AN/AN/A
6/30/202446531942N/A
3/31/20244463-1310N/A
12/31/202345522630N/A
9/30/2023409142650N/A
6/30/202341919-203N/A
3/31/202341615-126N/A
12/31/2022391-19-311N/A
9/30/2022389-8-47-36N/A
6/30/2022328-7-27-18N/A
3/31/2022308-2-19N/A
12/31/20212754-12-2N/A
9/30/20212311-27-12N/A
6/30/2021207-7-20-6N/A
3/31/2021174-5-36-24N/A
12/31/2020164-7-24-13N/A
9/30/20201783-9-4N/A
6/30/2020172359N/A
3/31/202017401418N/A
12/31/2019167-182832N/A
9/30/2019167-231822N/A
6/30/2019160-182630N/A
3/31/2019142-262933N/A
12/31/2018145-82227N/A
9/30/2018129-133137N/A
6/30/2018133-11N/A18N/A
6/30/201794-12N/A19N/A
12/31/201641-6N/A-1N/A
12/31/20155-1N/A-1N/A

애널리스트 미래 성장 예측

수입 대 저축률: BIOX 의 연간 예상 수익 증가율( 42.3% )이 saving rate( 2.6% 보다 높습니다. ).

수익 vs 시장: BIOX 의 연간 수익( 42.3% ) US 시장( 15.4% 보다 빠르게 성장할 것으로 예상됩니다. 15.4% 연간).

고성장 수익: BIOX 의 수입은 향후 3년 동안 상당히 증가할 것으로 예상됩니다.

수익 대 시장: BIOX 의 수익(연간 9.6% ) US 시장( 8.9% 보다 빠르게 성장할 것으로 예상됩니다. 8.9% 연간).

고성장 수익: BIOX 의 수익(연간 9.6% )은 연간 20% 보다 느리게 증가할 것으로 예상됩니다.


주당 순이익 성장 예측


미래 자기자본 수익률

미래 ROE: BIOX 의 자기자본수익률이 3년 내에 높을 것으로 예상되는지 판단하기에는 데이터가 부족합니다.


성장 기업 발견